Industry Research Reports
Global Urokinase Market Insights, Forecast to 2030
Industry: Pharma & Healthcare
Published Date: 2024-04-07
Pages: 89 Pages
Report ld: 2709084
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Urokinase Market Size(US$)
CAGR 2024-2030
5.2%
Market Size,2030
USD 64
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 48 million
Market Forecast in 2030(Value)
US$ 64 million
CAGR
5.2%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
The global Urokinase market is projected to grow from US$ 48 million in 2024 to US$ 64 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period.
Global key players of urokinase include Syner-Med, LIVZON, Wanhua Biochem, etc. The top three players hold a share about 50%. China is the largest market of Urokinase, holding a share about 56%, followed by Europe and North America.
Report Covers:
This report presents an overview of global market for Urokinase, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Urokinase, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Urokinase, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Urokinase sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Urokinase market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Urokinase sales, projected growth trends, production technology, application and end-user industry.
MARKET SEGMENTATION
By Company
- Syner-Med
- Wanhua Biochem
- Jiangxi Haoran Bio-Pharma
- Jiangsu Aidea Pharmaceutical
- Techpool
- Microbic Biosystems
- LIVZON
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Urokinase Powder
- Urokinase Solution
Segment by Application
- Hospital
- Clinic
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Urokinase in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Urokinase manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Urokinase sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Urokinase Product Introduction
1.2 Market by Type
1.2.1 Global Urokinase Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Urokinase Powder
1.2.3 Urokinase Solution
1.3 Market by Application
1.3.1 Global Urokinase Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Urokinase Sales Estimates and Forecasts 2019-2030
2.2 Global Urokinase Revenue by Region
2.2.1 Global Urokinase Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Urokinase Revenue by Region (2019-2024)
2.2.3 Global Urokinase Revenue by Region (2025-2030)
2.2.4 Global Urokinase Revenue Market Share by Region (2019-2030)
2.3 Global Urokinase Sales Estimates and Forecasts 2019-2030
2.4 Global Urokinase Sales by Region
2.4.1 Global Urokinase Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Urokinase Sales by Region (2019-2024)
2.4.3 Global Urokinase Sales by Region (2025-2030)
2.4.4 Global Urokinase Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Urokinase Sales by Manufacturers
3.1.1 Global Urokinase Sales by Manufacturers (2019-2024)
3.1.2 Global Urokinase Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Urokinase in 2023
3.2 Global Urokinase Revenue by Manufacturers
3.2.1 Global Urokinase Revenue by Manufacturers (2019-2024)
3.2.2 Global Urokinase Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Urokinase Revenue in 2023
3.3 Global Key Players of Urokinase, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Urokinase Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Urokinase Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Urokinase, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Urokinase, Product Offered and Application
3.8 Global Key Manufacturers of Urokinase, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Urokinase Sales by Type
4.1.1 Global Urokinase Historical Sales by Type (2019-2024)
4.1.2 Global Urokinase Forecasted Sales by Type (2025-2030)
4.1.3 Global Urokinase Sales Market Share by Type (2019-2030)
4.2 Global Urokinase Revenue by Type
4.2.1 Global Urokinase Historical Revenue by Type (2019-2024)
4.2.2 Global Urokinase Forecasted Revenue by Type (2025-2030)
4.2.3 Global Urokinase Revenue Market Share by Type (2019-2030)
4.3 Global Urokinase Price by Type
4.3.1 Global Urokinase Price by Type (2019-2024)
4.3.2 Global Urokinase Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Urokinase Sales by Application
5.1.1 Global Urokinase Historical Sales by Application (2019-2024)
5.1.2 Global Urokinase Forecasted Sales by Application (2025-2030)
5.1.3 Global Urokinase Sales Market Share by Application (2019-2030)
5.2 Global Urokinase Revenue by Application
5.2.1 Global Urokinase Historical Revenue by Application (2019-2024)
5.2.2 Global Urokinase Forecasted Revenue by Application (2025-2030)
5.2.3 Global Urokinase Revenue Market Share by Application (2019-2030)
5.3 Global Urokinase Price by Application
5.3.1 Global Urokinase Price by Application (2019-2024)
5.3.2 Global Urokinase Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Urokinase Market Size by Type
6.1.1 US & Canada Urokinase Sales by Type (2019-2030)
6.1.2 US & Canada Urokinase Revenue by Type (2019-2030)
6.2 US & Canada Urokinase Market Size by Application
6.2.1 US & Canada Urokinase Sales by Application (2019-2030)
6.2.2 US & Canada Urokinase Revenue by Application (2019-2030)
6.3 US & Canada Urokinase Market Size by Country
6.3.1 US & Canada Urokinase Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Urokinase Sales by Country (2019-2030)
6.3.3 US & Canada Urokinase Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Urokinase Market Size by Type
7.1.1 Europe Urokinase Sales by Type (2019-2030)
7.1.2 Europe Urokinase Revenue by Type (2019-2030)
7.2 Europe Urokinase Market Size by Application
7.2.1 Europe Urokinase Sales by Application (2019-2030)
7.2.2 Europe Urokinase Revenue by Application (2019-2030)
7.3 Europe Urokinase Market Size by Country
7.3.1 Europe Urokinase Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Urokinase Sales by Country (2019-2030)
7.3.3 Europe Urokinase Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Urokinase Market Size
8.1.1 China Urokinase Sales (2019-2030)
8.1.2 China Urokinase Revenue (2019-2030)
8.2 China Urokinase Market Size by Application
8.2.1 China Urokinase Sales by Application (2019-2030)
8.2.2 China Urokinase Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Urokinase Market Size by Type
9.1.1 Asia Urokinase Sales by Type (2019-2030)
9.1.2 Asia Urokinase Revenue by Type (2019-2030)
9.2 Asia Urokinase Market Size by Application
9.2.1 Asia Urokinase Sales by Application (2019-2030)
9.2.2 Asia Urokinase Revenue by Application (2019-2030)
9.3 Asia Urokinase Sales by Region
9.3.1 Asia Urokinase Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Urokinase Revenue by Region (2019-2030)
9.3.3 Asia Urokinase Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Urokinase Market Size by Type
10.1.1 Middle East, Africa and Latin America Urokinase Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Urokinase Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Urokinase Market Size by Application
10.2.1 Middle East, Africa and Latin America Urokinase Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Urokinase Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Urokinase Sales by Country
10.3.1 Middle East, Africa and Latin America Urokinase Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Urokinase Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Urokinase Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Syner-Med
11.1.1 Syner-Med Company Information
11.1.2 Syner-Med Overview
11.1.3 Syner-Med Urokinase Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Syner-Med Urokinase Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Syner-Med Recent Developments
11.2 Wanhua Biochem
11.2.1 Wanhua Biochem Company Information
11.2.2 Wanhua Biochem Overview
11.2.3 Wanhua Biochem Urokinase Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Wanhua Biochem Urokinase Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Wanhua Biochem Recent Developments
11.3 Jiangxi Haoran Bio-Pharma
11.3.1 Jiangxi Haoran Bio-Pharma Company Information
11.3.2 Jiangxi Haoran Bio-Pharma Overview
11.3.3 Jiangxi Haoran Bio-Pharma Urokinase Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Jiangxi Haoran Bio-Pharma Urokinase Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Jiangxi Haoran Bio-Pharma Recent Developments
11.4 Jiangsu Aidea Pharmaceutical
11.4.1 Jiangsu Aidea Pharmaceutical Company Information
11.4.2 Jiangsu Aidea Pharmaceutical Overview
11.4.3 Jiangsu Aidea Pharmaceutical Urokinase Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Jiangsu Aidea Pharmaceutical Urokinase Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Jiangsu Aidea Pharmaceutical Recent Developments
11.5 Techpool
11.5.1 Techpool Company Information
11.5.2 Techpool Overview
11.5.3 Techpool Urokinase Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Techpool Urokinase Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Techpool Recent Developments
11.6 Microbic Biosystems
11.6.1 Microbic Biosystems Company Information
11.6.2 Microbic Biosystems Overview
11.6.3 Microbic Biosystems Urokinase Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Microbic Biosystems Urokinase Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Microbic Biosystems Recent Developments
11.7 LIVZON
11.7.1 LIVZON Company Information
11.7.2 LIVZON Overview
11.7.3 LIVZON Urokinase Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 LIVZON Urokinase Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 LIVZON Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Urokinase Industry Chain Analysis
12.2 Urokinase Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Urokinase Production Mode & Process
12.4 Urokinase Sales and Marketing
12.4.1 Urokinase Sales Channels
12.4.2 Urokinase Distributors
12.5 Urokinase Customers
13 Market Dynamics
13.1 Urokinase Industry Trends
13.2 Urokinase Market Drivers
13.3 Urokinase Market Challenges
13.4 Urokinase Market Restraints
14 Key Findings in The Global Urokinase Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Urokinase Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Urokinase Powder
Table 3. Major Manufacturers of Urokinase Solution
Table 4. Global Urokinase Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Urokinase Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Urokinase Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Urokinase Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global Urokinase Revenue Market Share by Region (2019-2024)
Table 9. Global Urokinase Revenue Market Share by Region (2025-2030)
Table 10. Global Urokinase Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Urokinase Sales by Region (2019-2024) & (BIU)
Table 12. Global Urokinase Sales by Region (2025-2030) & (BIU)
Table 13. Global Urokinase Sales Market Share by Region (2019-2024)
Table 14. Global Urokinase Sales Market Share by Region (2025-2030)
Table 15. Global Urokinase Sales by Manufacturers (2019-2024) & (BIU)
Table 16. Global Urokinase Sales Share by Manufacturers (2019-2024)
Table 17. Global Urokinase Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Urokinase Revenue Share by Manufacturers (2019-2024)
Table 19. Global Key Players of Urokinase, Industry Ranking, 2022 VS 2023 VS 2024
Table 20. Urokinase Price by Manufacturers 2019-2024 (US$/MIU)
Table 21. Global Urokinase Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Urokinase by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urokinase as of 2023)
Table 23. Global Key Manufacturers of Urokinase, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Urokinase, Product Offered and Application
Table 25. Global Key Manufacturers of Urokinase, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Urokinase Sales by Type (2019-2024) & (BIU)
Table 28. Global Urokinase Sales by Type (2025-2030) & (BIU)
Table 29. Global Urokinase Sales Share by Type (2019-2024)
Table 30. Global Urokinase Sales Share by Type (2025-2030)
Table 31. Global Urokinase Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Urokinase Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Urokinase Revenue Share by Type (2019-2024)
Table 34. Global Urokinase Revenue Share by Type (2025-2030)
Table 35. Urokinase Price by Type (2019-2024) & (US$/MIU)
Table 36. Global Urokinase Price Forecast by Type (2025-2030) & (US$/MIU)
Table 37. Global Urokinase Sales by Application (2019-2024) & (BIU)
Table 38. Global Urokinase Sales by Application (2025-2030) & (BIU)
Table 39. Global Urokinase Sales Share by Application (2019-2024)
Table 40. Global Urokinase Sales Share by Application (2025-2030)
Table 41. Global Urokinase Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Urokinase Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Urokinase Revenue Share by Application (2019-2024)
Table 44. Global Urokinase Revenue Share by Application (2025-2030)
Table 45. Urokinase Price by Application (2019-2024) & (US$/MIU)
Table 46. Global Urokinase Price Forecast by Application (2025-2030) & (US$/MIU)
Table 47. US & Canada Urokinase Sales by Type (2019-2024) & (BIU)
Table 48. US & Canada Urokinase Sales by Type (2025-2030) & (BIU)
Table 49. US & Canada Urokinase Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada Urokinase Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada Urokinase Sales by Application (2019-2024) & (BIU)
Table 52. US & Canada Urokinase Sales by Application (2025-2030) & (BIU)
Table 53. US & Canada Urokinase Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada Urokinase Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada Urokinase Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada Urokinase Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada Urokinase Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada Urokinase Sales by Country (2019-2024) & (BIU)
Table 59. US & Canada Urokinase Sales by Country (2025-2030) & (BIU)
Table 60. Europe Urokinase Sales by Type (2019-2024) & (BIU)
Table 61. Europe Urokinase Sales by Type (2025-2030) & (BIU)
Table 62. Europe Urokinase Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe Urokinase Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe Urokinase Sales by Application (2019-2024) & (BIU)
Table 65. Europe Urokinase Sales by Application (2025-2030) & (BIU)
Table 66. Europe Urokinase Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe Urokinase Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe Urokinase Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe Urokinase Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe Urokinase Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe Urokinase Sales by Country (2019-2024) & (BIU)
Table 72. Europe Urokinase Sales by Country (2025-2030) & (BIU)
Table 73. China Urokinase Sales by Type (2019-2024) & (BIU)
Table 74. China Urokinase Sales by Type (2025-2030) & (BIU)
Table 75. China Urokinase Revenue by Type (2019-2024) & (US$ Million)
Table 76. China Urokinase Revenue by Type (2025-2030) & (US$ Million)
Table 77. China Urokinase Sales by Application (2019-2024) & (BIU)
Table 78. China Urokinase Sales by Application (2025-2030) & (BIU)
Table 79. China Urokinase Revenue by Application (2019-2024) & (US$ Million)
Table 80. China Urokinase Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia Urokinase Sales by Type (2019-2024) & (BIU)
Table 82. Asia Urokinase Sales by Type (2025-2030) & (BIU)
Table 83. Asia Urokinase Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia Urokinase Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia Urokinase Sales by Application (2019-2024) & (BIU)
Table 86. Asia Urokinase Sales by Application (2025-2030) & (BIU)
Table 87. Asia Urokinase Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Urokinase Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia Urokinase Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia Urokinase Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia Urokinase Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia Urokinase Sales by Region (2019-2024) & (BIU)
Table 93. Asia Urokinase Sales by Region (2025-2030) & (BIU)
Table 94. Middle East, Africa and Latin America Urokinase Sales by Type (2019-2024) & (BIU)
Table 95. Middle East, Africa and Latin America Urokinase Sales by Type (2025-2030) & (BIU)
Table 96. Middle East, Africa and Latin America Urokinase Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Urokinase Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America Urokinase Sales by Application (2019-2024) & (BIU)
Table 99. Middle East, Africa and Latin America Urokinase Sales by Application (2025-2030) & (BIU)
Table 100. Middle East, Africa and Latin America Urokinase Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Urokinase Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Urokinase Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America Urokinase Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Urokinase Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Urokinase Sales by Country (2019-2024) & (BIU)
Table 106. Middle East, Africa and Latin America Urokinase Sales by Country (2025-2030) & (BIU)
Table 107. Syner-Med Company Information
Table 108. Syner-Med Description and Major Businesses
Table 109. Syner-Med Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2019-2024)
Table 110. Syner-Med Urokinase Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Syner-Med Recent Developments
Table 112. Wanhua Biochem Company Information
Table 113. Wanhua Biochem Description and Major Businesses
Table 114. Wanhua Biochem Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2019-2024)
Table 115. Wanhua Biochem Urokinase Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Wanhua Biochem Recent Developments
Table 117. Jiangxi Haoran Bio-Pharma Company Information
Table 118. Jiangxi Haoran Bio-Pharma Description and Major Businesses
Table 119. Jiangxi Haoran Bio-Pharma Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2019-2024)
Table 120. Jiangxi Haoran Bio-Pharma Urokinase Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Jiangxi Haoran Bio-Pharma Recent Developments
Table 122. Jiangsu Aidea Pharmaceutical Company Information
Table 123. Jiangsu Aidea Pharmaceutical Description and Major Businesses
Table 124. Jiangsu Aidea Pharmaceutical Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2019-2024)
Table 125. Jiangsu Aidea Pharmaceutical Urokinase Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Jiangsu Aidea Pharmaceutical Recent Developments
Table 127. Techpool Company Information
Table 128. Techpool Description and Major Businesses
Table 129. Techpool Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2019-2024)
Table 130. Techpool Urokinase Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Techpool Recent Developments
Table 132. Microbic Biosystems Company Information
Table 133. Microbic Biosystems Description and Major Businesses
Table 134. Microbic Biosystems Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2019-2024)
Table 135. Microbic Biosystems Urokinase Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Microbic Biosystems Recent Developments
Table 137. LIVZON Company Information
Table 138. LIVZON Description and Major Businesses
Table 139. LIVZON Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2019-2024)
Table 140. LIVZON Urokinase Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. LIVZON Recent Developments
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Urokinase Distributors List
Table 145. Urokinase Customers List
Table 146. Urokinase Market Trends
Table 147. Urokinase Market Drivers
Table 148. Urokinase Market Challenges
Table 149. Urokinase Market Restraints
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Urokinase Product Picture
Figure 2. Global Urokinase Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Urokinase Market Share by Type in 2023 & 2030
Figure 4. Urokinase Powder Product Picture
Figure 5. Urokinase Solution Product Picture
Figure 6. Global Urokinase Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Urokinase Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Urokinase Report Years Considered
Figure 12. Global Urokinase Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Urokinase Revenue 2019-2030 (US$ Million)
Figure 14. Global Urokinase Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 15. Global Urokinase Revenue Market Share by Region (2019-2030)
Figure 16. Global Urokinase Sales 2019-2030 ((BIU)
Figure 17. Global Urokinase Sales Market Share by Region (2019-2030)
Figure 18. US & Canada Urokinase Sales YoY (2019-2030) & (BIU)
Figure 19. US & Canada Urokinase Revenue YoY (2019-2030) & (US$ Million)
Figure 20. Europe Urokinase Sales YoY (2019-2030) & (BIU)
Figure 21. Europe Urokinase Revenue YoY (2019-2030) & (US$ Million)
Figure 22. China Urokinase Sales YoY (2019-2030) & (BIU)
Figure 23. China Urokinase Revenue YoY (2019-2030) & (US$ Million)
Figure 24. Asia (excluding China) Urokinase Sales YoY (2019-2030) & (BIU)
Figure 25. Asia (excluding China) Urokinase Revenue YoY (2019-2030) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Urokinase Sales YoY (2019-2030) & (BIU)
Figure 27. Middle East, Africa and Latin America Urokinase Revenue YoY (2019-2030) & (US$ Million)
Figure 28. The Urokinase Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 29. The Top 5 and 10 Largest Manufacturers of Urokinase in the World: Market Share by Urokinase Revenue in 2023
Figure 30. Global Urokinase Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 31. Global Urokinase Sales Market Share by Type (2019-2030)
Figure 32. Global Urokinase Revenue Market Share by Type (2019-2030)
Figure 33. Global Urokinase Sales Market Share by Application (2019-2030)
Figure 34. Global Urokinase Revenue Market Share by Application (2019-2030)
Figure 35. US & Canada Urokinase Sales Market Share by Type (2019-2030)
Figure 36. US & Canada Urokinase Revenue Market Share by Type (2019-2030)
Figure 37. US & Canada Urokinase Sales Market Share by Application (2019-2030)
Figure 38. US & Canada Urokinase Revenue Market Share by Application (2019-2030)
Figure 39. US & Canada Urokinase Revenue Share by Country (2019-2030)
Figure 40. US & Canada Urokinase Sales Share by Country (2019-2030)
Figure 41. U.S. Urokinase Revenue (2019-2030) & (US$ Million)
Figure 42. Canada Urokinase Revenue (2019-2030) & (US$ Million)
Figure 43. Europe Urokinase Sales Market Share by Type (2019-2030)
Figure 44. Europe Urokinase Revenue Market Share by Type (2019-2030)
Figure 45. Europe Urokinase Sales Market Share by Application (2019-2030)
Figure 46. Europe Urokinase Revenue Market Share by Application (2019-2030)
Figure 47. Europe Urokinase Revenue Share by Country (2019-2030)
Figure 48. Europe Urokinase Sales Share by Country (2019-2030)
Figure 49. Germany Urokinase Revenue (2019-2030) & (US$ Million)
Figure 50. France Urokinase Revenue (2019-2030) & (US$ Million)
Figure 51. U.K. Urokinase Revenue (2019-2030) & (US$ Million)
Figure 52. Italy Urokinase Revenue (2019-2030) & (US$ Million)
Figure 53. Russia Urokinase Revenue (2019-2030) & (US$ Million)
Figure 54. China Urokinase Sales Market Share by Type (2019-2030)
Figure 55. China Urokinase Revenue Market Share by Type (2019-2030)
Figure 56. China Urokinase Sales Market Share by Application (2019-2030)
Figure 57. China Urokinase Revenue Market Share by Application (2019-2030)
Figure 58. Asia Urokinase Sales Market Share by Type (2019-2030)
Figure 59. Asia Urokinase Revenue Market Share by Type (2019-2030)
Figure 60. Asia Urokinase Sales Market Share by Application (2019-2030)
Figure 61. Asia Urokinase Revenue Market Share by Application (2019-2030)
Figure 62. Asia Urokinase Revenue Share by Region (2019-2030)
Figure 63. Asia Urokinase Sales Share by Region (2019-2030)
Figure 64. Japan Urokinase Revenue (2019-2030) & (US$ Million)
Figure 65. South Korea Urokinase Revenue (2019-2030) & (US$ Million)
Figure 66. China Taiwan Urokinase Revenue (2019-2030) & (US$ Million)
Figure 67. Southeast Asia Urokinase Revenue (2019-2030) & (US$ Million)
Figure 68. India Urokinase Revenue (2019-2030) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Urokinase Sales Market Share by Type (2019-2030)
Figure 70. Middle East, Africa and Latin America Urokinase Revenue Market Share by Type (2019-2030)
Figure 71. Middle East, Africa and Latin America Urokinase Sales Market Share by Application (2019-2030)
Figure 72. Middle East, Africa and Latin America Urokinase Revenue Market Share by Application (2019-2030)
Figure 73. Middle East, Africa and Latin America Urokinase Revenue Share by Country (2019-2030)
Figure 74. Middle East, Africa and Latin America Urokinase Sales Share by Country (2019-2030)
Figure 75. Brazil Urokinase Revenue (2019-2030) & (US$ Million)
Figure 76. Mexico Urokinase Revenue (2019-2030) & (US$ Million)
Figure 77. Turkey Urokinase Revenue (2019-2030) & (US$ Million)
Figure 78. Israel Urokinase Revenue (2019-2030) & (US$ Million)
Figure 79. GCC Countries Urokinase Revenue (2019-2030) & (US$ Million)
Figure 80. Urokinase Value Chain
Figure 81. Urokinase Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Urokinase in 2030?
The global market size of Urokinase in 2030 was 64 Million USD.
What is the annual compound growth rate of the global Urokinase market size from 2024 to 2030?
What was the global market size of Urokinase in 2024?
Which companies rank high in the global Urokinase market?
Which region is expected to have the highest market share?
Related Reports
Global Urokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Urokinase market size was US$ 82.09 million in 2025 and is forecast to reach a readjusted size of US$ 120 million by 2032 with a CAGR of 5.2% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 77
USD 4250.00
(Single User License)
Global Urokinase Market Research Report 2026
The global Urokinase market was valued at US$ 82.09 million in 2025 and is anticipated to reach US$ 120 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 116
USD 2900.00
(Single User License)
Urokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Urokinase was estimated to be worth US$ 82.09 million in 2025 and is projected to reach US$ 120 million, growing at a CAGR of 5.2% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 110
USD 3950.00
(Single User License)
Global Urokinase Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Urokinase market is projected to grow from US$ 49.8 million in 2024 to US$ 70.6 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 147
USD 4900.00
(Single User License)
Global Urokinase Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Urokinase was estimated to be worth US$ 49.8 million and is forecast to reach approximately US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 121
USD 5900.00
(Single User License)
Global Urokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Urokinase market size was US$ 49.8 million in 2024 and is forecast to a readjusted size of US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 79
USD 4250.00
(Single User License)
Urokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Urokinase was estimated to be worth US$ 49.8 million in 2024 and is forecast to a readjusted size of US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 95
USD 3950.00
(Single User License)
Global Urokinase Market Research Report 2025
The global market for Urokinase was valued at US$ 49.8 million in the year 2024 and is projected to reach a revised size of US$ 70.6 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Published Date: 2025-01-16
Pages: 79
USD 2900.00
(Single User License)
Global Urokinase Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published Date: 2024-04-17
Pages: 142
USD 5600.00
(Single User License)
Global Urokinase Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published Date: 2024-04-16
Pages: 137
USD 5900.00
(Single User License)
Global Urokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Urokinase market size was US$ 82.09 million in 2025 and is forecast to reach a readjusted size of US$ 120 million by 2032 with a CAGR of 5.2% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 77
USD 4250.00 (Single User License)Global Urokinase Market Research Report 2026
The global Urokinase market was valued at US$ 82.09 million in 2025 and is anticipated to reach US$ 120 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-01-04
Pages: 116
USD 2900.00 (Single User License)Urokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Urokinase was estimated to be worth US$ 82.09 million in 2025 and is projected to reach US$ 120 million, growing at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-01-04
Pages: 110
USD 3950.00 (Single User License)Global Urokinase Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Urokinase market is projected to grow from US$ 49.8 million in 2024 to US$ 70.6 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 147
USD 4900.00 (Single User License)Global Urokinase Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Urokinase was estimated to be worth US$ 49.8 million and is forecast to reach approximately US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 121
USD 5900.00 (Single User License)Global Urokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Urokinase market size was US$ 49.8 million in 2024 and is forecast to a readjusted size of US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 79
USD 4250.00 (Single User License)Urokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Urokinase was estimated to be worth US$ 49.8 million in 2024 and is forecast to a readjusted size of US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 95
USD 3950.00 (Single User License)Global Urokinase Market Research Report 2025
The global market for Urokinase was valued at US$ 49.8 million in the year 2024 and is projected to reach a revised size of US$ 70.6 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Published: 2025-01-16
Pages: 79
USD 2900.00 (Single User License)Global Urokinase Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published: 2024-04-17
Pages: 142
USD 5600.00 (Single User License)Global Urokinase Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published: 2024-04-16
Pages: 137
USD 5900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now